Athira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

November 10, 2021 at 11:50 AM EST

Supporting Materials

Print Page
Email Alerts
Contact IR